The DOI matches its Crossref record; 145 of the 167 references it cites were found in a registry or an index.
Repair of O6-alkylguanine by alkyltransferases
Abstract
The predominant pathway for the repair of O(6)-methylguanine in DNA is via the activity of an alkyltransferase protein that transfers the methyl group to a cysteine acceptor site on the protein itself. This review article describes recent studies on this alkyltransferase. The protein repairs not only methyl groups but also 2-chloroethyl-, benzyl- and pyridyloxobutyl-adducts. It acts on double-stranded DNA by flipping the O(6)-guanine adduct out of the DNA helix and into a binding pocket. The free base, O(6)-benzylguanine, is able to bind in this pocket and react with the cysteine, rendering it an effective inactivator of mammalian alkyltransferases. The alkylated form of the protein is rapidly degraded by the ubiquitin/proteasomal system. Some tumor cells do not express alkyltransferase despite having an intact gene. Methylation of key sites in CpG-rich islands in the promoter region are involved in this silencing and a change in the nuclear localization of an enhancer binding protein may also contribute. The alkyltransferase promoter contains Sp1, GRE and AP-1 sites and is slightly inducible by glucocorticoids and protein kinase C activators. There is a complex relationship between p53 and alkyltransferase expression with p53 mediating a rise in alkyltransferase in response to ionizing radiation but having no clear effect on basal levels. DNA adducts at the O(6)-position of guanine are a major factor in the carcinogenic, mutagenic, apoptopic and clastogenic actions of methylating agents and chloroethylating agents. Studies with transgenic mice in which alkyltransferase levels are increased or decreased confirm the importance of this repair pathway in protecting against carcinogenesis. Alkyltransferase activity in tumors protects them from therapeutic agents such as temozolomide and BCNU. This resistance is abolished by O(6)-benzylguanine and this drug is currently in clinical trials to enhance cancer chemotherapy by these agents. Studies are in progress to reduce the toxicity of such therapy towards the bone marrow by gene therapy to express alkyltransferases with mutations imparting resistance to O(6)-benzylguanine at high levels in marrow stem cells. Several polymorphisms in the human alkyltransferase gene have been identified but the significance of these in terms of alkyltransferase action is currently unknown.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The MGMT, DUSP22, CDCA2, ID2, TNFRSF1B, ZNF681, and IGSF21 may have a role in the etiology and pathogenesis of this disease.[31][32][33][34][35][36][37][38][39][40]”
From Altered genome-wide methylation in endometriosis (2014) · cites this paper as [32]
Citations
Cites
Esteller, M., Hamilton, S. R., Burger, P. C., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 1,253
Pegg, A. E. (1990) · PubMed · Cited by 734
Self-citationREGULATION AND EXPRESSION OF THE ADAPTIVE RESPONSE TO ALKYLATING AGENTS
Lindahl, T. L., Sedgwick, B., Sekiguchi, M., & Nakabeppu, Y. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.001025 · Cited by 650
Structure, Function, and Inhibition of O6-Alkylguanine-DNA Alkyltransferase
Pegg, A. E., Dolan, M. E., & Moschel, R. C. (1995) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60879-x · Cited by 506
Self-citationParikh, S. S., Mol, C. D., Slupphaug, G., Bharati, S., Krokan, H. E., & Tainer, J. A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5214 · Cited by 497
Roberts, R. J., & Cheng, X. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.181 · Cited by 315
Jaeckle, K. A., Eyre, H. J., Townsend, J. J., Schulman, S., Knudson, H. M., Belanich, M., Yarosh, D. B., Bearman, S., Giroux, D. J., & Schold, S. C. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3310 · Cited by 297
Involvement of the Mismatch Repair System in Temozolomide-Induced Apoptosis
D’Atri, S., Tentori, L., Lacal, P. M., Graziani, G., Pagani, E., Benincasa, E., Zambruno, G., Bonmassar, E., & Jiricny, J. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.2.334 · Cited by 282
Repair of DNA containing O 6 ‐alkylguanine
Pegg, A. E., & Byers, T. L. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.6.1544541 · Cited by 244
Self-citationSrivenugopal, K. S., Yuan, X., Friedman, H. S., & Ali‐Osman, F. (1996) · Biochemistry · doi:10.1021/bi9518205 · Cited by 218
Research works printed but not linked: 6
- Kaur, 1999, Role of the O6-alkylguanine DNA alkyltransferase codons 143 and 160 polymorphisms in lung cancer risk, Proc. Am. Assoc. Cancer Res., 40, A1646
- Egyhazi, 1999, Novel polymorphisms in the O6-methylguanine DNA methyltransferase gene in human melanoma, Proc. Am. Assoc. Cancer Res., 40, A3093
- Crone, 1999, Ubiquitin-mediated proteolysis of O6-alkylguanine-DNA alkyltransferase following inactivation with O6-benzylguanine, Proc. Am. Assoc. Cancer Res., 40, A2656
- Herfath, 1999, A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers, Mol. Carcinog., 24, 90, 10.1002/(SICI)1098-2744(199902)24:2<90::AID-MC3>3.0.CO;2-B · DOI
- Middleton, 1999, O6-(4-Bromothenyl)-guanine is an effective inactivator of O6-alkylguanine-DNA alkyltransferase, and improves the therapeutic index of temozolomide to a greater extent than O6-benzylguanine, Proc. Am. Assoc. Cancer Res., 40, A39
- Friedman, 1999, The biology of sensitivity and resistance to the molecule (temozolomide), Proc. Am. Assoc. Cancer Res., 40, 754
Cited by
Sorted by citations
Items 201–300 of 576
Chemotherapy resistance abrogation in metastatic melanoma.
Tawbi, H. A.-H., & Buch, S. C. (2010) · PubMed · Cited by 34
O 6 ‐alkylguanine‐DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer
Chae, M. H., Jang, J., Kang, H., Park, J. H., Park, J. M., Lee, W. K., Kam, S., Lee, E. B., Son, J. W., & Park, J. Y. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20171 · Cited by 34
“O(6)-alkylguanine-DNA alkyltransferase (AGT) is a DNA repair protein that removes mutagenic O(6)-alkylguanine (O(6)AG) DNA adducts that are formed by alkylating agents such as tobacco-specific 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) [5,6].”
BackgroundInfluentialDNA repair in hybrid fish of the genus Xiphophorus
David, W. M., Mitchell, D. L., & Walter, R. B. (2004) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cca.2004.07.006 · Cited by 34
Mijal, R. S., Kanugula, S., Vu, C. C., Fang, Q., Pegg, A. E., & Peterson, L. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3803 · Cited by 34
“Nucleotide excision repair is thought to play a role in the repair of bulky O(6)-alkylguanine adducts (11).”
BackgroundSelf-citationThe Evolution of SNAP-Tag Labels
Dreyer, R., Pfukwa, R., Barth, S., Hunter, R., & Klumperman, B. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.2c01238 · Cited by 33
McManus, F. P., Fang, Q., Booth, J. D. M., Noronha, A. M., Pegg, A. E., & Wilds, C. J. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c0ob00093k · Cited by 33
Self-citationMutT homologue 1 (MTH1) catalyzes the hydrolysis of mutagenic O6-methyl-dGTP
Jemth, A., Gustafsson, R., Bräutigam, L., Henriksson, L., Vallin, K. S. A., Sarno, A., Almlöf, I., Homan, E. J., Rasti, A., Berglund, U. W., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky896 · Cited by 30
Heterogeneity of Human Glioblastoma: Glutathione-S-Transferase and Methylguanine-Methyltransferase
Juillerat‐Jeanneret, L., Bernasconi, C. C., Bricod, C., Gros, S., Trepey, S., Benhattar, J., & Janzer, R. C. (2008) · Cancer Investigation · doi:10.1080/07357900802072913 · Cited by 35
Repair of O4-Alkylthymine by O6-Alkylguanine-DNA Alkyltransferases
Fang, Q., Kanugula, S., Tubbs, J. L., Tainer, J. A., & Pegg, A. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.045518 · Cited by 33
Self-citationShibata, T. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl117 · Cited by 33
Pauly, G. T., Loktionova, N. A., Fang, Q., Vankayala, S. L., Guida, W. C., & Pegg, A. E. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800675p · Cited by 32
Self-citationIshiguro, K., Zhu, Y.-L., Shyam, K., Penketh, P. G., Baumann, R. P., & Sartorelli, A. C. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.022 · Cited by 32
“AGT is a unique DNA damage repair protein in that the transfer of an alkyl group to an AGT active site cysteine results in a stoichiometric irreversible inactivation of the protein [15,16].”
BackgroundInfluentialRole of O6-alkylguanine-DNA alkyltransferase in the cytotoxic activity of cloretazine
Ishiguro, K., Shyam, K., Penketh, P. G., & Sartorelli, A. C. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0169 · Cited by 32
“The O(6)-alkylguanine-specific repair protein AGT (12) was considered the most likely cause of the differential sensitivity.”
BackgroundFujikane, R., Komori, K., Sekiguchi, M., & Hidaka, M. (2016) · Scientific Reports · doi:10.1038/srep31714 · Cited by 31
Christov, P. P., Angel, K. C., Guengerich, F. P., & Rizzo, C. J. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900047c · Cited by 31
Interactions of Human O6-Alkylguanine-DNA Alkyltransferase (AGT) with Short Double-Stranded DNAs
Melikishvili, M., Rasimas, J. J., Pegg, A. E., & Fried, M. G. (2008) · Biochemistry · doi:10.1021/bi801666c · Cited by 31
Self-citationCui, B., Johnson, S. P., Bullock, N., Ali‐Osman, F., Bigner, D. D., & Friedman, H. S. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.053124 · Cited by 32
“These results demonstrate that the modulation of AGT by O6-BG potentiates Chk1 activation by BCNU, thus indicating that alkylation at the O6 position of guanine or the subsequently formed DNA interstrand cross-links are the primary BCNU-induced DNA lesions that trigger Chk1 activation.”
BackgroundInfluentialJesień-Lewandowicz, E., Jesionek‐Kupnicka, D., Zawlik, I., Szybka, M., Kulczycka-Wojdala, D., Rieske, P., Sieruta, M., Jaskólski, D. J., Och, W., Skowroński, W., et al. (2008) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2008.09.015 · Cited by 31
“Brain tumors expressing low levels of MGMT are more sensitive to chemotherapy based on alkylating agents, and MGMT depletion by Oebenzylguanine enhances the therapeutic efficacy in vitro and in patients [1,16,17].”
BackgroundIdentification of WISP1 as a novel oncogene in glioblastoma
Jing, D., Zhang, Q., Yu, H., Zhao, Y., & Shen, L. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4119 · Cited by 32
Roos, W. P., Jöst, E., Belohlavek, C., Nagel, G., Fritz, G., & Kaina, B. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3498 · Cited by 30
DNA-Reactive Protein Monoepoxides Induce Cell Death and Mutagenesis in Mammalian Cells
Tretyakova, N. Y., Michaelson-Richie, E. D., Gherezghiher, T. B., Kurtz, J., Ming, X., Wickramaratne, S., Campion, M., Kanugula, S., Pegg, A. E., & Campbell, C. (2013) · Biochemistry · doi:10.1021/bi400273m · Cited by 30
Self-citationMIAO, W., Liu, X., Wang, H., Fan, Y., Lian, S., Yang, X., Wang, X., GUO, G., LI, Q., & WANG, S. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3255 · Cited by 30
Nakasu, S., Fukami, T., Jito, J., & Matsuda, M. (2007) · Surgical Neurology · doi:10.1016/j.surneu.2006.12.053 · Cited by 30
“apeutic alkylating agents [10,28].”
Mostofa, A., Punganuru, S. R., Madala, H. R., & Srivenugopal, K. S. (2018) · Neoplasia · doi:10.1016/j.neo.2018.01.010 · Cited by 30
Active‐site alkylation destabilizes human O6‐alkylguanine DNA alkyltransferase
Rasimas, J. J., Dalessio, P. A., Ropson, I. J., Pegg, A. E., & Fried, M. G. (2003) · Protein Science · doi:10.1110/ps.03319404 · Cited by 30
“However, it disappears rapidly from cells treated with DNA-alkylating agents or O6-benzylguanine (Pegg et al. 1995; Pegg 2000).”
BackgroundSelf-citationMishina, Y. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh319 · Cited by 30
Copper carbenes alkylate guanine chemoselectively through a substrate directed reaction
Geigle, S. N., Wyss, L. A., Sturla, S. J., & Gillingham, D. G. (2016) · Chemical Science · doi:10.1039/c6sc03502g · Cited by 29
Valdebenito, S., Damico, D. C. S., & Eugenín, E. A. (2019) · Cancer Reports · doi:10.1002/cnr2.1220 · Cited by 29
The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies
Maksoud, S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02915-2 · Cited by 29
Tancredi, A., Gusyatiner, O., Bady, P., Buri, M. C., Lomazzi, R., Chiesi, D., Messerer, M., & Hegi, M. E. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05497-y · Cited by 29
Topologies of Complexes Containing O6-Alkylguanine–DNA Alkyltransferase and DNA
Adams, C., Melikishvili, M., Rodgers, D. W., Rasimas, J. J., Pegg, A. E., & Fried, M. G. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.03.067 · Cited by 29
Self-citationPerugino, G., Miggiano, R., Serpe, M., Vettone, A., Valenti, A., Lahiri, S., Rossi, F., Rossi, M., Rizzi, M., & Ciaramella, M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv774 · Cited by 30
An Update on the Epigenetics of Glioblastomas
Ferreira, W. A. S., Pinheiro, D. D. R., da Costa, C. A., Rodrigues-Antunes, S., Araújo, M. D., Barros, M. B. L., Teixeira, A. C. D. S., Faro, T. A. S., Burbano, R. M. R., de Oliveira, E. H. C., et al. (2016) · Epigenomics · doi:10.2217/epi-2016-0040 · Cited by 29
Association Between MGMT Promoter Methylation and Breast Cancer: a Meta-Analysis
An, N., Shi, Y., Ye, P., Pan, Z., & Long, X. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000480196 · Cited by 29
Genotoxic effects of myosmine in a human esophageal adenocarcinoma cell line
Vogt, S., Fuchs, K., & Richter, E. (2006) · Toxicology · doi:10.1016/j.tox.2006.01.025 · Cited by 29
Nagel, Z. D., Beharry, A. A., Mazzucato, P., Kitange, G. J., Sarkaria, J. N., Kool, E. T., & Samson, L. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0208341 · Cited by 28
Ma, S., Egyházi, S., Martenhed, G., Ringborg, U. K., & Hansson, J. (2002) · Melanoma Research · doi:10.1097/00008390-200208000-00005 · Cited by 28
Beharry, A. A., Nagel, Z. D., Samson, L. D., & Kool, E. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152684 · Cited by 28
“However, fluorophore-labeled BG (or SNAP-tag probes) are poor substrates for wild-type MGMT [19,39] and as a consequence the fluorescence response with enzyme was slow, requiring high concentrations of probe (5 μM) to produce signals on a timescale of hours.”
BackgroundPromoter methylation of O6-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53
Lai, J.-C., Cheng, Y., Goan, Y.-G., Chang, J. T., Wu, T., Chen, C., & Lee, H. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.04.016 · Cited by 28
Stratenwerth, B., Geisen, S. M., He, Y., Beltzig, L., Sturla, S. J., & Kaina, B. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0228 · Cited by 29
Yimit, A., Mitomi, H., Nakai, K., Himuro, T., Saito, T., Takahashi, M., Arakawa, A., Yao, T., & Saito, M. (2013) · Histopathology · doi:10.1111/his.12220 · Cited by 27
Thresholds for DNA-Reactive (Genotoxic) Organic Carcinogens
Williams, G. M., Iatropoulos, M. J., & Jeffrey, A. M. (2005) · Journal of Toxicologic Pathology · doi:10.1293/tox.18.69 · Cited by 27
A novel DNA damage recognition protein in Schizosaccharomyces pombe
Pearson, S. J. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl270 · Cited by 27
“The alkyl acceptor cysteine is part of the motif PCHRI/V that is found in all functional alkyltransferase proteins and substitution of this residue inactivates the protein ( 7 ).”
BackgroundPassagne, I., Evrard, A., Depeille, P., Cuq, P., Cupissol, D., & Vian, L. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.06.009 · Cited by 27
Novel DNA repair alkyltransferase from Caenorhabditis elegans
Kanugula, S., & Pegg, A. E. (2001) · Environmental and Molecular Mutagenesis · doi:10.1002/em.1077 · Cited by 27
“Many organisms have developed an effective mechanism to repair these mutagenic lesions through the action of O6-alkylguanine DNA-alkyltransferase (AGT) (EC 2.1.1.63) [Lindahl et al., 1988; Moore et al., 1994; Pegg et al., 1995; Pegg, 2000].”
BackgroundInfluentialSelf-citationPassagne, I., Evrard, A., Winum, J., Depeille, P., Cuq, P., Montero, J., Cupissol, D., & Vian, L. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051938 · Cited by 27
Raizer, J. J., Malkin, M. G., Kleber, M., & Abrey, L. E. (2004) · Neuro-Oncology · doi:10.1215/s1152851704000122 · Cited by 27
“Additionally, blockade or depletion of AGT may enhance the cytotoxicity of nitrosoureas and alkylating agents (Gerson, 2002; Pegg, 2000; Wedge et al., 1996).”
BackgroundInfluentialMilsom, M. D., & Williams, D. A. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.03.020 · Cited by 26
Senthong, P., Millington, C. L., Wilkinson, O. J., Marriott, A. S., Watson, A. J., Reamtong, O., Eyers, C. E., Williams, D. M., Margison, G. P., & Povey, A. C. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1476 · Cited by 26
Ramirez, Y. P., Mladek, A. C., Phillips, R. M., Gynther, M., Rautio, J., Ross, A. H., Wheelhouse, R. T., & Sakaria, J. N. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0113 · Cited by 27
Rahman, M. A., Khatun, M. T., Mim, A. K., Khandocar, M. P., Rahman, A., Hasan, M. H., Shimki, A. I., Hossain, M. S., Shoily, M. S. A., Faraque, A., et al. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01845-9 · Cited by 27
“Understanding mutations and polymorphisms in critical DNA repair genes should pave the way for more effective treatments for degenerative disorders [208 – 210].”
DNA Repair Mechanisms and Therapeutic Targets in Glioma
Elmore, K. B., & Schaff, L. R. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01077-z · Cited by 24
Lee, K.-H., Kim, S., Kim, E. E., Shim, Y., Won, J., Park, C., Choi, S. H., Yun, H., Lee, H., & Park, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-32153-y · Cited by 25
Loh, Y. H., Mitrou, P. N., Bowman, R., Wood, A., Jeffery, H., Luben, R., Lentjes, M. A. H., Khaw, K., & Rodwell, S. A. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.01.002 · Cited by 25
Du, H.-B., Sun, J., Chen, Z., Nie, J., Tong, J., & Li, J. (2012) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2012.690088 · Cited by 25
“MGMT protein is a DNA repair enzyme involved in the transfer of methyl groups and other small alkyl groups at the O 6 position of guanine to a cysteine acceptor site of the protein in an auto-inactivating reaction ( Pegg 2000 ).”
BackgroundMarple, T. C., Li, H., & Hasty, P. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.05.004 · Cited by 25
Liu, L., Schwartz, S., Davis, B. M., & Gerson, S. L. (2002) · PubMed · Cited by 25
Gibson, D. R., Vo, A. H., Lambing, H., Bhattacharya, P., Tahir, P., Chehab, F. F., & Butowski, N. A. (2024) · BMC Neurology · doi:10.1186/s12883-024-03605-3 · Cited by 24
Lee, S., Lee, E. J., Ko, Y. H., Lee, S. H., Maeng, L.-S., & Kim, K. (2009) · Apmis · doi:10.1111/j.1600-0463.2008.00017.x · Cited by 23
Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animals
Hansen, R. J., Ludeman, S. M., Paikoff, S. J., Pegg, A. E., & Dolan, M. E. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.03.010 · Cited by 24
“MGMT activity is restored in the cell after de novo synthesis [7,8].”
BackgroundSelf-citationAlkyltransferase-like proteins: molecular switches between DNA repair pathways
Tubbs, J. L., & Tainer, J. A. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0405-8 · Cited by 24
“DNA O(6)-alkylguanine (O(6)-alkylG) lesions are mostly repaired through the action of alkyltransferase proteins, such as Ada and Ogt in Escherichia coli, and O(6)-alkylguanine-DNA alkyltransferase (AGT) (also known as O(6)-methylguanine-DNA methyltransferase, MGMT, in humans), which are widespread amongst prokaryotes…”
Crosbie, P. A. J., McGown, G., Thorncroft, M. R., O’Donnell, E., Barber, P. V., Lewis, S. J., Harrison, K., Agius, R. M., Santibanez‐Koref, M., Margison, G. P., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23059 · Cited by 24
Cheng, W., Li, M., Jiang, Y., Zhang, C., Cai, J., Wang, K., & Wu, A. (2015) · Journal of neurosurgery · doi:10.3171/2015.5.jns142437 · Cited by 24
Comparative proteogenomic characterization of glioblastoma
Asif, S., Fatima, R., Krc, R., Bennett, J., & Raza, S. (2019) · CNS Oncology · doi:10.2217/cns-2019-0003 · Cited by 25
Hiraga, J., Kinoshita, T., Ohno, T., Mori, N., Ohashi, H., Fukami, S., Noda, A., Ichikawa, A., & Naoe, T. (2006) · International Journal of Hematology · doi:10.1532/ijh97.06087 · Cited by 24
Huang, J., Ye, F., Chen, H., Lu, W., & Xie, X. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm003 · Cited by 24
“Methyltransferase activity between human fibroblast cultures from different individuals varies as much as 20-fold, suggesting that genetic polymorphisms in MGMT are risk factors for the development of cancer [34-36].”
BackgroundLees, N. P. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh111 · Cited by 24
“O6-Methylguanine levels will however depend not only on exposure but also upon the level of O6-alkylguanine DNA-alkyltransferase (MGMT), which repairs O6-methylguanine and becomes inactivated in the process ( 4 ,5).”
BackgroundMethodInfluentialDolan, M. E., Posner, M. C., Karrison, T. G., Radosta, J. M., Steinberg, G. D., BERTUCCI, D. C., Vujasin, L., & Ratain, M. J. (2002) · PubMed · Cited by 24
Miggiano, R., Perugino, G., Ciaramella, M., Serpe, M., Rejman, D., Páv, O., Pohl, R., Garavaglia, S., Lahiri, S., Rizzi, M., et al. (2015) · Biochemical Journal · doi:10.1042/bj20150833 · Cited by 23
Nakamichi, I., Tomita, Y., Zhang, B., Sugiyama, H., Kanakura, Y., Fukuhara, S., Hino, M., Kanamaru, A., Ogawa, H., & Aozasa, K. (2007) · Annals of Hematology · doi:10.1007/s00277-007-0299-1 · Cited by 24
“activity is supposed to play a major role in resistance to alkylating agents [ 21 ].”
BackgroundAlkyltransferase-Mediated Toxicity of 1,3-Butadiene Diepoxide
Kalapila, A. G., Loktionova, N. A., & Pegg, A. E. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800178t · Cited by 23
Self-citationJena, N. R., & Bansal, M. (2011) · Physical Biology · doi:10.1088/1478-3975/8/4/046007 · Cited by 23
Lung cancer risk and variation in MGMT activity and sequence
Povey, A. C., Margison, G. P., & Santibanez‐Koref, M. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.03.022 · Cited by 23
Cloudy apple juice protects against chemical-induced oxidative stress in rat
Kujawska, M., Ignatowicz, E., Ewertowska, M., Markowski, J., & Jodynis‐Liebert, J. (2010) · European Journal of Nutrition · doi:10.1007/s00394-010-0114-y · Cited by 23
“High doses of alkylating agents caused a depletion of this repair mechanism [ 34 ].”
BackgroundKrajnović, M., Radojković, M., Davidović, R. S., Dimitrijević, B., & Krtolica, K. (2012) · Medical Oncology · doi:10.1007/s12032-012-0441-3 · Cited by 22
Ameya, P., Nathan, I., Konduri, S. D., George, C., Francis, A.-O., Mohd, A., Surendra, R., Madala, H. R., Basak, D., Mostofa, A. G. M., et al. (2016) · Journal of Biomedical Research · doi:10.7555/jbr.30.20160040 · Cited by 22
Progression of O6-methylguanine-DNA methyltransferase and temozolomide resistance in cancer research
Jiang, G., Jiang, A., Xin, Y., Li, L., Qian, C., & Zheng, J. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3549-z · Cited by 22
Javanmard, S., Loktionova, N. A., Fang, Q., Pauly, G. T., Pegg, A. E., & Moschel, R. C. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0705859 · Cited by 22
“O6-Benzyl-3′-O-(γ-folyl)-2′-deoxyguanosine (1)”
BackgroundSelf-citationStructural studies of MJ1529, an O6-methylguanine-DNA methyltransferase
Roberts, A., Pelton, J. G., & Wemmer, D. E. (2006) · Magnetic Resonance in Chemistry · doi:10.1002/mrc.1823 · Cited by 22
Lees, N. P., Harrison, K., Hall, C. N., Margison, G. P., & Povey, A. C. (2006) · Gut · doi:10.1136/gut.2006.097899 · Cited by 22
The best of both worlds: Chemigenetic fluorescent sensors for biological imaging
Tsao, K., Imai, S., Chang, M., Hario, S., Terai, T., & Campbell, R. E. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.08.002 · Cited by 21
Svec, R. L., McKee, S. A., Berry, M. R., Kelly, A. M., Fan, T. M., & Hergenrother, P. J. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00022 · Cited by 24
Gibson, D., Ravi, A., Rodriguez, E., Chang, S. M., Bush, N. A. O., Taylor, J. W., Clarke, J. L., Solomon, D. A., Scheffler, A., Witte, J. S., et al. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad115 · Cited by 21
“4,5,9,10 Furthermore, AGT does not associate or work in concert with other transcription-coupled repair proteins, indicating AGT ’s in-dependence as a repair mechanism.”
BackgroundMatsuno, A., Murakami, M., Hoya, K., Yamada, S. M., Miyamoto, S., Yamada, S., Son, J.-H., Nishido, H., Ide, F., Nagashima, H., et al. (2013) · Medical Molecular Morphology · doi:10.1007/s00795-013-0050-z · Cited by 21
“Among many mechanisms of resistance to alkylating agents, the expression of MGMT has a protective effect against cell death induced by alkylating agents, showing a strong correlation between MGMT activity and drug resistance [43, 44].”
BackgroundProtective effect of chokeberry on chemical-induced oxidative stress in rat
Kujawska, M., Ignatowicz, E., Ewertowska, M., Oszmiański, J., & Jodynis‐Liebert, J. (2010) · Human & Experimental Toxicology · doi:10.1177/0960327110371697 · Cited by 21
Yamauchi, K., Kakinuma, S., 須藤, 聡., Kito, S., Ohta, Y., Nohmi, T., Masumura, K., Nishimura, M., & Shimada, Y. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2007.12.001 · Cited by 21
Duarte, M. P., Palma, B. B., Laires, A., Oliveira, J. S., Rueff, J., & Kranendonk, M. (2005) · Mutagenesis · doi:10.1093/mutage/gei028 · Cited by 21
Chen, S., Zhang, Y., & Zhang, D. (2015) · Scientific Reports · doi:10.1038/srep14723 · Cited by 21
Mécanismes de réparation et mutagenèse radio-induite chez les eucaryotes supérieurs
Averbeck, D. (2000) · Cancer/Radiothérapie · doi:10.1016/s1278-3218(00)00008-1 · Cited by 20
The delayed genotoxic effect of N-nitroso N-propoxur insecticide in mammalian cells
Lin, C., Wei, L., & Wang, T.-C. (2006) · Food and Chemical Toxicology · doi:10.1016/j.fct.2006.11.015 · Cited by 20
Xu, M., Nekhayeva, I., Cross, C. E., Rondelli, C. M., Wickliffe, J. K., & Abdel-Rahman, S. Z. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt355 · Cited by 20
Guza, R., Rajesh, M. P., Fang, Q., Pegg, A. E., & Tretyakova, N. Y. (2006) · Chemical Research in Toxicology · doi:10.1021/tx050348d · Cited by 20
Self-citationMerlo, R., Caprioglio, D., Cillo, M., Valenti, A., Mattossovich, R., Morrone, C., Massarotti, A., Rossi, F., Miggiano, R., Leonardi, A., et al. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2020.1841182 · Cited by 19
Farzanehfar, M., Vossoughinia, H., Jabini, R., Tavassoli, A., Saadatnia, H., Khorashad, A. K., Ahadi, M., Afzalaghaee, M., Karimiani, E. G., Mirzaei, F., et al. (2013) · DNA and Cell Biology · doi:10.1089/dna.2012.1949 · Cited by 18
“The DNA repair protein encoded by the O 6 -methylguanine-DNA methyltransferase (MGMT) gene is involved in defending cells against alkylating agents (Pegg, 2000; Kaina et al. , 2001).”
Degradation of BRCA2 in Alkyltransferase-Mediated DNA Repair and Its Clinical Implications
Philip, S., Swaminathan, S., Kuznetsov, S. G., Kanugula, S., Biswas, K., Chang, S., Loktionova, N. A., Haines, D. C., Kaldis, P., Pegg, A. E., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1179 · Cited by 20
“AGT functions by transferring the alkyl group from the O 6 position of guanine in DNA to a cysteine residue within its active site ( 20 ).”
Self-citationHellman, L. M., Spear, T. J., Koontz, C. J., Melikishvili, M., & Fried, M. G. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku659 · Cited by 19
Caporaso, P., Turriziani, M., Venditti, A., Marchesi, F., Buccisano, F., Tirindelli, M. C., Alvino, E., Garbin, A., Tortorelli, G., Toppo, L., et al. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.03.016 · Cited by 19
Morrone, C., Miggiano, R., Serpe, M., Massarotti, A., Valenti, A., del Monaco, G., Rossi, M., Rossi, F., Rizzi, M., Perugino, G., et al. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.10.020 · Cited by 19
Inhibition of human DNA polymerase β activity by the anticancer prodrug Cloretazine
Frederick, A. M., Davis, M. L., & Rice, K. P. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.042 · Cited by 19
Melikishvili, M., Rodgers, D. W., & Fried, M. G. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.09.007 · Cited by 19
“Is FAM a prototype drug? The DNA-alkyltransferase activity of AGT protects tumor cells from toxic effects of DNA-alkylating chemotherapeutic drugs [8,44,59].”
Background
Metadata
- Authors
- Pegg, A. E.
- Affiliations
- Pennsylvania State University (US)
- Corresponding author
- Pegg, Anthony E
- Venue
- Mutation Research/Reviews in Mutation Research
- Publisher
- Elsevier BV
- Published
- 2000-04
- Volume
- 462
- Issue
- 2-3
- Pages
- 83-100
- ISSN
- 1383-5742 (ISSN-L)
- OpenAlex
- W1999549596
- Cited by
- 576
- References
- 167
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 16 · 2023: 12 · 2022: 11 · 2021: 10 · 2020: 15 · 2019: 17 · 2018: 13 · 2017: 14 · 2016: 16 · 2015: 21 · 2014: 30 · 2013: 36 · 2012: 26
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Mutation Research/Reviews in Mutation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA57725, CA-18137, R01CA071976, CA 71976)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- O6-alkylguanine, alkyltransferase, DNA repair, O6-methylguanine, O6-benzylguanine, alkylating agents, ubiquitin-proteasome degradation, promoter methylation, gene silencing, p53, temozolomide resistance, transgenic mice, myelosuppression
- MeSH terms
- Animals, DNA Repair, Guanine, Humans, DNA Adducts, Alkyl and Aryl Transferases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review